Skip to main content

and
  1. No Access

    Article

    ASO Visual Abstract: Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the United States

    Mustafa Raoof MD, Richard L. Whelan MD, Kevin M. Sullivan MD in Annals of Surgical Oncology (2023)

  2. Article

    Open Access

    Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA

    Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a laparoscopic locoregional treatment for peritoneal metastases (PM) from colorectal cancer (CRC) or appendiceal cancer (AC) in patients who cann...

    Mustafa Raoof MD, Richard L. Whelan MD, Kevin M. Sullivan MD in Annals of Surgical Oncology (2023)

  3. No Access

    Article

    PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial

    Peritoneal metastases (PM) from ovarian, gastric, appendiceal, or colorectal origin can be treated via cytoreductive surgery with or without the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) fo...

    Mustafa Raoof MD, Gautam Malhotra MD, PhD, Adrian Kohut MD in Annals of Surgical Oncology (2022)

  4. No Access

    Article

    Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy

    Based on the activity of menadione (M) in the human tumor stem cell assay, we conducted a phase I trial of M in patients with advanced cancer. Forty patients (19 men, 21 women) were treated with 90 courses of ...

    Dean Lim MD, Robert J. Morgan Jr., Steven Akman, Kim Margolin in Investigational New Drugs (2005)